Replimune Group, Inc. (REPL)
6.98
+0.09
(+1.31%)
USD |
NASDAQ |
Mar 20, 16:00
7.00
+0.02
(+0.29%)
After-Hours: 20:00
Replimune Group Accounts Payable (Quarterly) : 5.647M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| REGENXBIO, Inc. | 21.36M |
| ANI Pharmaceuticals, Inc. | 62.58M |
| Phathom Pharmaceuticals, Inc. | 4.983M |
| Catalyst Pharmaceuticals, Inc. | 11.20M |
| Sarepta Therapeutics, Inc. | 280.84M |